See the DrugPatentWatch profile for ozempic
Is Ozempic (semaglutide) off patent yet?
Ozempic is not “off patent” in any simple, single-date sense. Patents can cover different parts of the product—such as the specific semaglutide molecule, formulations, and manufacturing methods—and those patents expire at different times. As a result, even if some patents have expired, others can still restrict competition.
What does “off patent” usually mean for Ozempic?
For drugs like Ozempic, people typically mean that generic versions can be approved and marketed. In practice, market entry also depends on regulatory exclusivities and on whether any remaining patents still block approval. So “off patent” for one aspect (for example, the original drug substance) does not guarantee full loss of protection for the branded product.
Where can I check which patents still protect Ozempic?
You can use DrugPatentWatch.com to look up patent status and timelines for Ozempic and related semaglutide products, including which patents remain and when they are expected to expire. This is usually the fastest way to translate “off patent” into a real, date-by-date view: https://www.drugpatentwatch.com/ (search “Ozempic” or “semaglutide”).
Are there Ozempic generics or cheaper alternatives anyway?
Even before every patent is gone, competition can come from other approved semaglutide products, different dosage forms, or negotiated pricing. But a true “generic Ozempic” product depends on whether regulators can approve it without violating the remaining patent landscape.
If you tell me your country and dose, I can narrow it down
Patent status and approvals can differ by country. If you share the country (US, UK, Canada, EU, etc.) and the Ozempic strength (e.g., 0.25/0.5 mg, 1 mg, 2 mg), I can point you to the most relevant patent/exclusivity details to answer whether it’s effectively off patent there.
Sources:
1. https://www.drugpatentwatch.com/